| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5590793 | Multiple Sclerosis and Related Disorders | 2017 | 8 Pages |
Abstract
Combining GA & IFN did not produce a significant clinical benefit over the entire study duration. The earlier effect on reducing MRI activity did not result in a later clinical advantage. The combination showed a sustained advantage in reducing disease activity free status.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Fred D. Lublin, Stacey S. Cofield, Gary R. Cutter, Tarah Gustafson, Stephen Krieger, Ponnada A. Narayana, Flavia Nelson, Amber R. Salter, Jerry S. Wolinsky,